All public logs
Jump to navigation
Jump to search
Combined display of all available logs of HemOnc.org - A Hematology Oncology Wiki. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)- 01:03, 2 May 2024 Jwarner talk contribs created page Category:Guideline pages (Created page with "Category:General reference pages")
- 21:54, 28 April 2024 Jwarner talk contribs created page Tovorafenib (Ojemda) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tovorafenib NCI Drug Dictionary]: An orally available inhibitor of wild-type...")
- 23:06, 22 April 2024 Jwarner talk contribs created page Nogapendekin alfa inbakicept (Anktiva) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nogapendekin-alfa NCI Drug Dictionary]: A fusion protein complex composed of...")
- 10:38, 14 April 2024 Jwarner talk contribs moved page Iptacopan (LNP-023) to Iptacopan (Fabhalta) (FDA approval)
- 18:05, 12 April 2024 Jwarner talk contribs created page CARv3-TEAM-E T-cells (Created page with "==Mechanism of action== anti-EGFR CAR T-cells ==Preliminary data== ===Glioblastoma=== #'''INCIPIENT:''' Choi BD, Gerstner ER, Frigault MJ, Leick MB, Mount CW, Balaj L, Ni...")
- 18:00, 12 April 2024 Jwarner talk contribs created page Category:SPEAR T-cells (Created page with "Category:Immune effector cells")
- 18:00, 12 April 2024 Jwarner talk contribs created page Category:Anti-MAGE-A4 SPEAR T-cells (Created page with "Category:SPEAR T-cells")
- 17:59, 12 April 2024 Jwarner talk contribs created page Category:Liposarcoma medications (investigational) (Created page with "Category:Liposarcoma medications")
- 17:59, 12 April 2024 Jwarner talk contribs created page Afamitresgene Autoleucel (ADP-A2M4) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afamitresgene-autoleucel NCI Drug Dictionary]: A preparation of autologous h...")
- 12:40, 10 April 2024 Jwarner talk contribs created page Hereditary hemorrhagic telangiectasia - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:25, 10 April 2024 Jwarner talk contribs created page Sickle cell anemia - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 11:21, 10 April 2024 Jwarner talk contribs created page Smoldering multiple myeloma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 11:34, 9 April 2024 Jwarner talk contribs created page Category:FDA withdrawn in 2024 (Created page with "Category:Discontinued drugs")
- 17:43, 30 March 2024 Jwarner talk contribs created page Category:Myeloid neoplasms (Created page with "Category:Malignant hematologic neoplasm")
- 13:24, 4 March 2024 Jwarner talk contribs created page Category:Pyruvate kinase deficiency regimens (Created page with "Category:Classical hematology regimens")
- 13:23, 4 March 2024 Jwarner talk contribs created page Category:Pyruvate kinase deficiency medications (Created page with "Category:Classical hematology medications")
- 13:22, 4 March 2024 Jwarner talk contribs created page Pyruvate kinase deficiency (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 14:32, 28 February 2024 Jwarner talk contribs created page Category:Medications by manufacturing method (Created page with "Category:Drugs")
- 14:32, 28 February 2024 Jwarner talk contribs created page Category:Recombinant medications (Created page with "Category:Medications by manufacturing method")
- 14:27, 28 February 2024 Jwarner talk contribs created page Category:Profibrinolytics (Created page with "Category:Classical hematology medications")
- 14:06, 28 February 2024 Jwarner talk contribs created page Category:Hemoglobin S polymerization inhibitors (Created page with "Category:Classical hematology medications")
- 13:08, 24 February 2024 Jwarner talk contribs created page Category:Antineoplastic bispecific antibodies (Created page with "Category:Targeted therapeutic Category:Bispecific antibody medications")
- 13:05, 24 February 2024 Jwarner talk contribs created page Category:Hematologic bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 13:04, 24 February 2024 Jwarner talk contribs created page Category:Immunostimulatory bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 12:35, 2 February 2024 Jwarner talk contribs moved page Momelotinib (CYT-387) to Momelotinib (Ojjaara) (FDA approval)
- 12:35, 2 February 2024 Jwarner talk contribs created page Category:EMA approved in 2024 (Created page with "Category:EMA approved drugs")
- 21:49, 23 January 2024 Jwarner talk contribs moved page Ovarian cancer, BRCA-mutated to Ovarian cancer, HRD-positive (Renaming to make the page more generic for HRD rather than just BRCA)
- 02:02, 20 January 2024 Jwarner talk contribs created page Category:Bcl-2 translation inhibitors (Created page with "Category:Apoptosis promoters")
- 02:02, 20 January 2024 Jwarner talk contribs created page Oblimersen (Genasense) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium NCI Drug Dictionary]: The sodium salt of a phosphorothioat...")
- 15:41, 19 January 2024 Jwarner talk contribs created page Category:Ornithine decarboxylase inhibitors (Created page with "Category:Enzyme inhibitors")
- 15:41, 19 January 2024 Jwarner talk contribs created page Eflornithine (Iwilfin) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eflornithine-hydrochloride NCI Drug Dictionary]: A difluoromethylated ornith...")
- 01:26, 19 January 2024 Jwarner talk contribs created page Category:Complement pathway inhibitors (Created page with "Category:Hematology medications")
- 01:25, 19 January 2024 Jwarner talk contribs created page Category:Complement factor D inhibitors (Created page with "Category:Complement pathway inhibitors")
- 01:24, 19 January 2024 Jwarner talk contribs created page Danicopan (ALXN-2040) (Created page with "==Mechanism of action== Complement factor D inhibitor ==Preliminary data== ===Paroxysmal nocturnal hemoglobinuria (PNH)=== #'''ALPHA:'...")
- 18:06, 18 January 2024 Jwarner talk contribs created page Category:Anti-DLL3-CD3 bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 18:05, 18 January 2024 Jwarner talk contribs created page Tarlatamab (AMG-757) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: A bispecific T-cell engager (BiTE) antibody composed of two single-chain variable fragments (scFv), one directed against...")
- 12:18, 12 January 2024 Jwarner talk contribs created page Category:Cutaneous T-cell lymphoma medications (investigational) (Created page with "Category:Cutaneous T-cell lymphoma medications")
- 11:42, 6 January 2024 Jwarner talk contribs created page Category:Hepatic veno-occlusive disease medications (Created page with "Category:Supportive medications")
- 11:36, 6 January 2024 Jwarner talk contribs created page Category:Acute lymphoblastic leukemia medications (Created page with "Category:Leukemia medications")
- 11:36, 6 January 2024 Jwarner talk contribs created page Category:Acute lymphoblastic leukemia, infant medications (Created page with "Category:Acute lymphoblastic leukemia medications")
- 02:30, 2 January 2024 Jwarner talk contribs created page Category:FDA approved in 2024 (Created page with "Category:FDA approved drugs")
- 03:33, 30 December 2023 Jwarner talk contribs created page Hypereosinophilic syndrome - null regimens (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. These references provide further insight into the historical development o...")
- 13:59, 20 December 2023 Jwarner talk contribs created page Category:FAK inhibitors (Created page with "Category:Tyrosine kinase inhibitors")
- 13:58, 20 December 2023 Jwarner talk contribs created page Repotrectinib (Augtyro) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repotrectinib NCI Drug Dictionary]: An orally available inhi...")
- 00:18, 17 December 2023 Jwarner talk contribs created page Glioblastoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 01:26, 2 December 2023 Jwarner talk contribs created page Autologous stem cells (Created page with "==General information== Class/mechanism: Hematopoietic stem/progenitor cells from the individual who is receiving the infusion <br>Route: IV <br>Extravasation: No information...")
- 23:46, 27 November 2023 Jwarner talk contribs moved page Nirogacestat (PF-03084014) to Nirogacestat (Ogsiveo) (FDA approval)
- 17:31, 26 November 2023 Jwarner talk contribs moved page Category:Local therapies to Category:Locally delivered therapies
- 15:13, 26 November 2023 Jwarner talk contribs created page Category:Cellular therapy regimens (Created page with "Category:Regimen index")
- 15:10, 26 November 2023 Jwarner talk contribs moved page Chimeric antigen receptor T cells (CAR-T) to Cellular therapy conditioning regimens